| Net income | |
| Depreciation and amortization | |
| Equity based compensation | 13.27M |
| Tax benefit from exercise/vesting of equity awards | |
| Deferred financing charges | 609K |
| Equity in loss of joint venture | |
| Accounts receivable, net | -315.43M |
| Inventories | -4.99M |
| Income taxes, net | 48.53M |
| Prepaid expenses and other current assets | 5.85M |
| Other assets, net | |
| Accounts payable, accrued expenses and other liabilities | 40.82M |
| Net cash used in operating activities | |
| Investment in equity of joint venture | |
| Capital expenditures | |
| Net cash used in investing activities | |
| Proceeds from notes payable, net | 91.33M |
| Proceeds from exercise of equity awards | 260K |
| Excess tax benefit from exercise/vesting of equity awards | |
| Net cash provided by financing activities | |
| Effect of exchange rate changes | -457K |
| Net decrease in cash and cash equivalents | -87.59M |
| Cash and cash equivalents at beginning of period | 132.59M |
| Cash and cash equivalents at end of period | 45M |
| Interest | 3.16M |
| Income taxes | -7.53M |